Area of research
Pediatrics, Perinatology and Child Health · Neurology
Research interest
Research interests include Childhood Cancer Survivors' Quality of Life, Neuroblastoma Research and Treatments, Legionella and Acanthamoeba research, and Acute Lymphoblastic Leukemia research.
The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent <scp>CNS</scp> and <scp>head‐and‐neck</scp> cancer patients: A report from the <scp>PanCareLIFE</scp> consortium
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30‐year SIOP‐RTSG experience
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study